Bank of New York Mellon
PRAX icon

Bank of New York Mellon’s Praxis Precision Medicines PRAX Stock Holding History

Bank of New York Mellon’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6M Sell
85,376
-1,671
-2% -$529K ﹤0.01% 1405
2026
Q1 		$28M Buy
87,047
+9,150
+12% +$2.83M 0.01% 1349
2025
Q4 		$23M Buy
77,897
+21,609
+38% +$4.02M ﹤0.01% 1465
2025
Q3 		$2.98M Buy
56,288
+3,735
+7% +$181K ﹤0.01% 2604
2025
Q2 		$2.21M Buy
52,553
+6,246
+13% +$238K ﹤0.01% 2698
2025
Q1 		$1.75M Sell
46,307
-549
-1% -$34.3K ﹤0.01% 2760
2024
Q4 		$3.61M Sell
46,856
-1,351
-3% -$97.8K ﹤0.01% 2462
2024
Q3 		$2.77M Sell
48,207
-1,303
-3% -$70.4K ﹤0.01% 2594
2024
Q2 		$2.05M Buy
+49,510
New +$2.34M ﹤0.01% 2777
2023
Q4 		– Sell
-5,005
Closed -$128K – 4370
2023
Q3 		$128K Buy
5,005
+4,023
+410% +$76.1K ﹤0.01% 4049
2023
Q2 		$16.9K Sell
982
-7,482
-88% -$115K ﹤0.01% 4304
2023
Q1 		$103K Buy
8,464
+545
+7% +$23K ﹤0.01% 4072
2022
Q4 		$283K Hold
7,919
– – ﹤0.01% 3821
2022
Q3 		$269K Buy
7,919
+1,003
+15% +$50K ﹤0.01% 3887
2022
Q2 		$254K Sell
6,916
-385
-5% -$41.1K ﹤0.01% 3961
2022
Q1 		$1.12M Buy
7,301
+129
+2% +$26.5K ﹤0.01% 3244
2021
Q4 		$2.12M Buy
7,172
+266
+4% +$78K ﹤0.01% 2961
2021
Q3 		$1.92M Buy
6,906
+2,311
+50% +$627K ﹤0.01% 2998
2021
Q2 		$1.26M Buy
4,595
+2,378
+107% +$852K ﹤0.01% 3273
2021
Q1 		$1.09M Buy
2,217
+239
+12% +$170K ﹤0.01% 3281
2020
Q4 		$1.63M Buy
+1,978
New +$1.15M ﹤0.01% 2966

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon's PRAX Position: Q2 2026 in Review

Bank of New York Mellon reduced its Praxis Precision Medicines (PRAX) stake by 1.9% in Q2 2026, selling an estimated $529K and leaving 85,376 shares worth $28.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1405.

Bank of New York Mellon first reported a position in PRAX in Q4 2020 and has held it in 21 quarters since. 127 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Bank of New York Mellon held 85,376 shares of Praxis Precision Medicines worth $28.6M as of Q2 2026.
  • Bank of New York Mellon sold 1,671 Praxis Precision Medicines shares in Q2 2026, an estimated $529K.
  • Praxis Precision Medicines made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #1405 holding.
  • Bank of New York Mellon first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 21 quarters since.
  • 127 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.